We have located links that may give you full text access.
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Management of renal arterial disease in the elderly patient.
Surgery, Gynecology & Obstetrics 1987 August
From 1979 until 1984, 70 elderly (greater than or equal to 65 years of age) patients with atherosclerotic renal arterial disease underwent surgical revascularization (SR, N = 46) or percutaneous transluminal renal angioplasty (PTRA, N = 24). After SR, there were no operative deaths and seven major complications. After PTRA, there were six major complications, including two deaths. The clinical success rate with SR was better than with PTRA both in terms of amelioration of hypertension (100.0 versus 27.3 per cent) and preservation of renal function (85.0 versus 68.4 per cent). SR can be done safely and is the most effective treatment for elderly patients with renal artery disease.
Full text links
Related Resources
Trending Papers
Renin-Angiotensin-Aldosterone System: From History to Practice of a Secular Topic.International Journal of Molecular Sciences 2024 April 5
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Revascularization Strategy in Myocardial Infarction with Multivessel Disease.Journal of Clinical Medicine 2024 March 27
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app